What causes pulmonary hypertension

What is Pulmonary Hypertension?

Pulmonary hypertension (PH) is a serious medical condition characterized by high blood pressure in the arteries of the lungs and the right side of the heart. The lungs have their own circulatory system, separate from the body's systemic circulation. In PH, the blood vessels in the lungs become narrowed, blocked, or destroyed, making it difficult for blood to flow through them. This increased resistance forces the right ventricle of the heart to work harder to pump blood into the lungs, which can eventually lead to heart failure.

Causes of Pulmonary Hypertension

The causes of pulmonary hypertension are diverse and are categorized by the World Health Organization (WHO) into five main groups:

Group 1: Pulmonary Arterial Hypertension (PAH)

This group involves diseases of the small pulmonary arteries themselves. It includes:

• Idiopathic Pulmonary Arterial Hypertension (IPAH): In most cases of IPAH, the exact cause is unknown. It is thought to be related to genetic factors and changes in the cells lining the pulmonary arteries.
• Heritable Pulmonary Arterial Hypertension (HPAH): This form is caused by genetic mutations, often inherited from a parent. Certain genes, like BMPR2, are commonly implicated.
• Drug- and Toxin-Induced PAH: Certain medications, such as appetite suppressants (e.g., fenfluramine and dexfenfluramine, though largely withdrawn from the market) and some chemotherapy drugs, have been linked to PAH.
• Associated PAH (APAH): This occurs in conjunction with other conditions, including:
  • Connective tissue diseases (e.g., scleroderma, lupus, rheumatoid arthritis)
  • HIV infection
  • Congenital heart disease (certain types of holes or defects in the heart present at birth)
  • Portal hypertension (high blood pressure in the vein that carries blood from the digestive organs to the liver)
• Persistent Pulmonary Hypertension of the Newborn (PPHN): A condition affecting newborns where the circulatory system doesn't adapt properly after birth.

Group 2: Pulmonary Hypertension Due to Left Heart Disease

This is the most common type of PH. It occurs when problems with the left side of the heart (the chamber that pumps blood to the body) cause blood to back up into the lungs. Conditions include:

• Heart failure with preserved ejection fraction (HFpEF)
• Heart failure with reduced ejection fraction (HFrEF)
• Valvular heart disease (e.g., mitral or aortic valve disease)

Group 3: Pulmonary Hypertension Due to Lung Diseases and/or Hypoxia

Low oxygen levels in the blood, often due to chronic lung diseases, can cause the pulmonary arteries to constrict, leading to PH. Common lung conditions include:

• Chronic Obstructive Pulmonary Disease (COPD)
• Interstitial lung disease (e.g., idiopathic pulmonary fibrosis)
• Sleep apnea
• High-altitude exposure
• Developmental lung disorders

Group 4: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

This type of PH is caused by blood clots that have become organized and lodged in the pulmonary arteries, obstructing blood flow. If left untreated, these clots can lead to significant scarring and thickening of the artery walls, causing chronic high blood pressure.

Group 5: Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms

This group includes PH related to:

• Blood disorders (e.g., chronic hemolytic anemia)
• Systemic disorders (e.g., sarcoidosis)
• Metabolic disorders (e.g., glycogen storage disease)
• Other rare causes

Risk Factors

Several factors can increase the risk of developing pulmonary hypertension:

• Family history of PH
• Being female (PAH is more common in women)
• Obesity
• Certain autoimmune diseases
• History of blood clots in the lungs
• Living at high altitudes
• Use of certain drugs or toxins

Symptoms

Symptoms of PH often develop gradually and can be mistaken for other conditions. They include:

• Shortness of breath (dyspnea), initially during exertion, later at rest
• Fatigue
• Dizziness or fainting spells (syncope)
• Chest pressure or pain
• Swelling (edema) in the ankles, legs, and eventually the abdomen
• Bluish lips and skin (cyanosis)
• Heart palpitations

Diagnosis and Management

Diagnosing PH involves a combination of tests, including echocardiograms, right heart catheterization, lung function tests, and CT scans. Management focuses on treating the underlying cause, managing symptoms, and improving quality of life. Medications, oxygen therapy, and in some cases, surgery or lung transplantation may be considered.